title: Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients.
authors.forename: Brenda S
authors.initials: BS
authors.lastname: Clark
authors.forename: I-Fen
authors.initials: IF
authors.lastname: Chang
authors.forename: Saul J
authors.initials: SJ
authors.lastname: Karpen
authors.forename: Lydia
authors.initials: L
authors.lastname: Herrera
authors.forename: Jaymee D
authors.initials: JD
authors.lastname: Scott
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Bristow
authors.forename: Rubén E
authors.initials: RE
authors.lastname: Quirós-Tejeira
authors.forename: John A
authors.initials: JA
authors.lastname: Goss
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D007223:Infant; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy / Q000821:virology; D012189:Retrospective Studies; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir